PBT

Prana Biotechnology (PBT)

Tue, 22/07/2008 - 03:50

Stock Code

PBT

Stock Exchange

Australian Securities Exchange

Prana Biotechnology Limited (PBT) is a company engaged in researching about Alzheimer's disease as well as other type of age-related neurodegenerative diseases and disorders. It is also focused on developing pharmaceutical products that are exclusively designed and developed to treat and cure the root causes of the brain and eye degeneration as part of the aging processes. PBT was listed on the Australian Stock Exchange on the 28th of March 2000. Its average annual revenue reaches approximately $0.4 million out of its issued capital of approximately $53 million.

Syndicate content

Free Email Subscription to Share Trading

 My Share Trading Feed